The Indian pharmaceuticals market is the third largest in terms of volume and thirteenth largest in terms of value, as per a report by Equity Master. India is the largest provider of generic drugs globally with the Indian generics accounting for 20 per cent of global exports in terms of volume. Of late, consolidation has become an important characteristic of the Indian pharmaceutical market as the industry is highly fragmented.
India enjoys an important position in the global pharmaceuticals sector. The country also has a large pool of scientists and engineers who have the potential to steer the industry ahead to an even higher level. Presently over 80 per cent of the antiretroviral drugs used globally to combat AIDS (Acquired Immuno Deficiency Syndrome) are supplied by Indian pharmaceutical firms.
Benefits of Participation
• Brand promotion of products/ services
• Networking
• Generate Business leads
• Create/strengthen brand awareness
• Hold B2B interactions
Who Should Sponsor
• Healthcare IT Service Providers
• Pharmaceuticals Industry
• Medical Equipment & Device Manufacturers
• Banks / Financial Institutions
• Companies offering Healthcare Consultancy & Business Development Solutions
• Laboratories & Diagnostics Centers
• Hospital Design & Infrastructure Solutions Providers
• Those interested in Investing in Healthcare
Participants
• Pharmaceutical Industry
• Medical Device Industry
• Diplomatic Missions
• International Pharma & Medical Devices Associations and their members
• Commercial Counsellors of Different Countries
• Academicians /Researchers
• Technology Providers
• Government officials/Policy Makers/Regulators
• Consultants
• Financial Institutions
• Hospital Industry
We propose to deliberate on the following points during the conference.
a) To identify bottlenecks in the growth of the Pharma, Medical Devices and the Healthcare delivery sectors esp. in wake of increase in regulatory and licensing requirements
b) Pricing and Regulatory Issues of the Pharma Industry
c) Deliberations on the Medical Devices Rules and the Medical Devices Act and suggestions on recommendations for the same.
d) Discuss the gaps in the healthcare delivery and discuss and make recommendations on bridging the same for effective and broad-based delivery
We have invited Shri Ananth kumar, Hon’ble Union Minister of Chemicals & Fertilizers, Ministry of Chemicals & Fertilizers as a Chief Guest and Shri Mansukh L Mandaviya, Hon’ble Minister of State of Chemicals & Fertilizers, Ministry of Chemicals & Fertilizers, Govt of India as a Guest of Honour and Shri Jai Priye Prakash, Secretary, Ministry of Chemical & Fertilizers as a Special Guest.
FIND MORE CONFERENCES AT PHARMATUTOR
.png)
